Classification criteria for Sjogren's syndrome: A critical review

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 9-14

  Baldini, Chiara ^a   Talarico, Rosaria ^a   Tzioufas, Athanasios G ^b   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Classification criteria; Diagnosis; Rheumatoid factor; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY;

ARTHRALGIA; ARTHRITIS; AUTOIMMUNE THYROIDITIS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE CLASSIFICATION; HEMATOLOGIC DISEASE; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LYMPHOMA; PAROTID ENLARGEMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SJOEGREN SYNDROME; VASCULITIS; XEROPHTHALMIA; XEROSTOMIA;

AUTOANTIBODIES; HUMANS; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 84858415087     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.12.006     Document Type: Review

References (35)

1. Tzioufas A.G., Voulgarelis M. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007, 21(6):989-1010.
2. Hyphantis T., Mantis D., Voulgari P.V., Tsifetaki N., Drosos A.A. The psychological defensive profile of primary Sjögren's syndrome patients and its relationship to health-related quality of life. Clin Exp Rheumatol 2011, 29(3):485-493.
3. Priori R., Iannuccelli C., Alessandri C., Modesti M., Antonazzo B., Di Lollo A.C., et al. Fatigue in Sjögren's's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol 2010, 28(6 Suppl. 63):S82-S86.
4. Voulgarelis M., Moutsopoulos H.M. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. Rheum Dis Clin North Am 2008, 34(4):921-933. [viii].
5. Voulgarelis M., Tzioufas A.G., Moutsopoulos H.M. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008, 26(5 Suppl. 51):S66-S71.
6. Theander E., Jacobsson L.T. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008, 34(4):935-947. [viii-ix].
7. Jonsson R., Bolstad A.I., Brokstad K.A., Brun J.G. Sjögren's syndrome-a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007, 1108:433-447.
8. Manthorpe R., Oxholm P., Prause J.U., Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986, 61:19-21.
9. Fox R.I., Robinson C.A., Curd J.G., Kozin F., Howell F.V. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986, 29(5):577-585.
10. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36(3):340-347.
11. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. European study group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002, 61(6):554-558.
12. Manthorpe R. Sjögren's syndrome criteria. Ann Rheum Dis 2002, 61(6).
13. Brun J.G., Madland T.M., Gjesdal C.B., Bertelsen L.T. Sjögren's syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford) 2002, 41(3):301-304.
14. Locht H., Pelck R., Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev 2005, 4(5):276-281.
15. Novljan M.P., Rozman B., Jerse M., Rotar Z., Vidmar G., Kveder T., et al. Comparison of the different classification criteria sets for primary Sjögren's syndrome. Scand J Rheumatol 2006, 35(6):463-467.
16. Langegger C., Wenger M., Duftner C., Dejaco C., Baldissera I., Moncayo R., et al. Use of the European preliminary criteria, the Breiman-classification tree and the American-European criteria for diagnosis of primary Sjögren's Syndrome in daily practice: a retrospective analysis. Rheumatol Int 2007, 27(8):699-702.
17. Gálvez J., Sáiz E., López P., Pina M.F., Carrillo A., Nieto A., et al. Diagnostic evaluation and classification criteria in Sjögren's Syndrome. Jt Bone Spine 2009, 76(1):44-49.
18. Ramos-Casals M., Brito-Zerón P., Perez-De-Lis M., Jimenez I., Blanco M.J., Bove A., et al. Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2010, 38(2-3):178-185.
19. Vitali C., Bombardieri S., Moutsopoulos H.M., Coll J., Gerli R., Hatron P.Y., et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996, 55(2):116-121.
20. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev 2010, 9(5):A305-A310.
21. Binard A., Devauchelle-Pensec V., Fautrel B., Jousse S., Youinou P., Saraux A. Epidemiology of Sjögren's syndrome: where are we now?. Clin Exp Rheumatol 2007, 25(1):1-4.
22. Haugen A.J., Peen E., Hultén B., Johannessen A.C., Brun J.G., Halse A.K., et al. Estimation of the prevalence of primary Sjögren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008, 37(1):30-34.
23. Gøransson L.G., Haldorsen K., Brun J.G., Harboe E., Jonsson M.V., Skarstein K., et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011, 40(3):221-224.
24. Kabasakal Y., Kitapcioglu G., Turk T., Oder G., Ulusoy R., Mete N., et al. Prevalence of Sjögren's syndrome in Izmir, Turkey. Ann Rheum Dis 2004, 63(Suppl. I):503.
25. Birlik M., Akar S., Gurler O., Sari I., Sarioglu S., Birlik B., et al. Prevalence of primary Sjögren's syndrome in an urban population of Izmir, Turkey. Ann Rheum Dis 2004, 63(Suppl. I):502.
26. Ramos-Casals M., Tzioufas A.G., Stone J.H., Sisó A., Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA 2010, 304(4):452-460.
27. Moutsopoulos N.M., Katsifis G.E., Angelov N., Leakan R.A., Sankar V., Pillemer S., et al. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis 2008, 67(10):1437-1443.
28. Hartkamp A., Geenen R., Godaert G.L., Bootsma H., Kruize A.A., Bijlsma J.W., et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Ann Rheum Dis 2008, 67(1):91-97.
29. Devauchelle-Pensec V., Morvan J., Rat A.C., Jousse-Joulin S., Pennec Y., Pers J.O., et al. Effects of rituximab therapy on quality of life in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2011, 29(1):6-12.
30. Meijer J.M., Meiners P.M., Vissink A., Spijkervet F.K., Abdulahad W., Kamminga N., et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010, 62(4):960-968.
31. Saraux A. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome. Autoimmun Rev 2010, 9(9):609-614.
32. Seror R., Ravaud P., Bowman S.J., Baron G., Tzioufas A., Theander E., et al. EULAR Sjögren's Task Force. EULAR Sjögren's's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's's syndrome. Ann Rheum Dis 2010, 69(6):1103-1109.
33. Seror R., Mariette X., Bowman S., Baron G., Gottenberg J.E., Boostma H., et al. European league against rheumatism Sjögren's Task Force. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League against Rheumatism Sjögren's syndrome disease activity index. Arthritis Care Res (Hoboken) 2010, 62(4):551-558.
34. Seror R., Ravaud P., Mariette X., Bootsma H., Theander E., Hansen A., et al. EULAR Sjögren's Task Force. EULAR Sjögren's's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's's syndrome. Ann Rheum Dis 2011, 70(6):968-972.
35. Baldini C., Talarico R., Luciano N., Tavoni A., Bombardieri S. Are the revised American-European Consensus Criteria too stringent for primary Sjögren's Syndrome (pSS)? The experience on a large monocentric cohort of pSS patients. Ann Rheum Dis 2010, 69(Suppl3):391.